Status: Recruiting
A Study to Investigate the Pharmacokinetics, Pharmacodynamics, and Safety of NKF-PEG, and US-Neulasta in Healthy Adult Male Volunteers
A Single Center, Single-Dose, Double-Blind, Randomized, Two-Period, Crossover Study to Demonstrate Pharmacokinetic and Pharmacodynamic Similarity Between NKF-PEG, and US-Neulasta®, and to Evaluate Safety in Healthy Adult Male Volunteers
Participants needed: 202
Trial details
Phase: Phase 1Age: 18-55Biological sex: MaleType: InterventionalSponsor: Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.Updated: Jul 31, 2026Locations: 1
Eligibility criteria
Participant must be 18 to 55 years of age, at the time of signing the informed c... [+4]
Sensitivity to any of the study interventions, or components thereof including E... [+6]